Melior Labs Limited (12079476): administration
- Status
- Administration ended
- Administration began
- 2025-09-23
- Administrators
- Paul Steven Cooper, Paul Robert Appleton
- Administrators' firm
- Begbies Traynor
- Incorporated
- 2019-07-02
- Location
- London
- Industry
- 86900 Other human health activities
Why it went into administration
- Regulatory change or action
- HMRC / tax arrears
From the administrators' statement
The Company traded as a subscription based online digital healthcare platform, with expert medical care targeted at Testosterone Replacement Therapy (TRT), treatment of erectile dysfunction (ED) and other associated treatments connected particularly with testosterone deficiency. Initial capital was raised from various investors.
The Company started trading with initial subscribers of more than 100 people, recruiting employees and doctors and building what appeared to be a ‘fit-for-purpose’ digital platform.
In May 2023, the Company focused its efforts away from marketing and advertising, and instead on fund raising. However, the fund-raising efforts were unsuccessful and in view of the high burn rate, cost-saving measures were introduced to ensure the business could be kept as a going concern. With no realistic prospects of raising the required funding from existing investors, the original founders accepted offers from new Shareholders, accepting a mixture of debt and equity. Following this, the Company experienced a series of internal issues and conflicts which ultimately resulted in a restructure of the Company's constitution, which ultimately resulted in a transfer of control and management.
Administrators' statement of proposals (2025-11-18) · Companies House register